Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-22T18:59:57.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Maternal depressive symptoms throughout pregnancy are associated with increased placental glucocorticoid sensitivity

Published online by Cambridge University Press:  28 January 2015

R. M. Reynolds ,
A.-K. Pesonen ,
J. R. O'Reilly ,
S. Tuovinen ,
M. Lahti ,
E. Kajantie ,
P. M. Villa ,
H. Laivuori ,
E. Hämäläinen  and
J. R. Seckl
...Show all authors
R. M. Reynolds*
Affiliation:
Endocrinology Unit, University/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK
A.-K. Pesonen
Affiliation:
Institute of Behavioral Sciences, University of Helsinki, 00014 University of Helsinki, Helsinki, Finland
J. R. O'Reilly
Affiliation:
Endocrinology Unit, University/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK
S. Tuovinen
Affiliation:
Institute of Behavioral Sciences, University of Helsinki, 00014 University of Helsinki, Helsinki, Finland
M. Lahti
Affiliation:
Institute of Behavioral Sciences, University of Helsinki, 00014 University of Helsinki, Helsinki, Finland
E. Kajantie
Affiliation:
National Institute for Health and Welfare, 00271 Helsinki, Finland Children's Hospital, Helsinki University Central Hospital and University of Helsinki, 00029 Helsinki, Finland Department of Obstetrics and Gynaecology, Oulu University Hospital and University of Oulu, 90029 Oulu, Finland
P. M. Villa
Affiliation:
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
H. Laivuori
Affiliation:
Haartman Institute, Medical Genetics, University of Helsinki, 00014 University of Helsinki, Helsinki, Finland
E. Hämäläinen
Affiliation:
HUSLAB and Department of Clinical Chemistry, Helsinki University Central Hospital, 00014 University of Helsinki, Helsinki, Finland
J. R. Seckl
Affiliation:
Endocrinology Unit, University/BHF Centre for Cardiovascular Science, Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, UK
K. Räikkönen
Affiliation:
Institute of Behavioral Sciences, University of Helsinki, 00014 University of Helsinki, Helsinki, Finland
*
* Address for correspondence: R. Reynolds, Endocrinology Unit, BHF/University Centre for Cardiovascular Science, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK. (Email: R.Reynolds@ed.ac.uk)
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

Maternal prenatal depression predicts post-partum depression and increases risk of prematurity and low birth weight. These effects may be mediated by altered placental function. We hypothesized that placental function would be influenced by the gestational week of experiencing depressive symptoms and aimed to examine associations between maternal depressive symptoms during pregnancy and placental expression of genes involved in glucocorticoid and serotonin transfer between mother and fetus.

Method

We studied women participating in a prospective pregnancy cohort: the Prediction and Prevention of Preeclampsia (PREDO) Study, Helsinki, Finland. Maternal depressive symptoms were assessed at 2-week intervals throughout pregnancy in 56 healthy women with singleton, term pregnancies. Messenger ribonucleic acid (mRNA) levels of glucocorticoid (GR) and mineralocorticoid (MR) receptors and serotonin transporter (SLC6A4), 11β-hydroxysteroid dehydrogenase type 1 (HSD1) and 2 (HSD2) were quantified in placental biopsies.

Results

In adjusted analyses women who reported higher depressive symptoms across the whole pregnancy had higher mRNA levels of GR [effect size 0.31 s.d. units, 95% confidence interval (CI) 0.01–0.60, p = 0.042] and MR (effect size 0.34 s.d. units, 95% CI 0.01–0.68, p = 0.047). These effects were significant for symptoms experienced in the third trimester of pregnancy for GR; findings for MR were also significant for symptoms experienced in the second trimester. GR and MR mRNA levels increased linearly by having the trimester-specific depressive symptoms scores 0, 1 or 2–3 times above the clinical cut-off for depression (p = 0.003, p = 0.049, respectively, and p = 0.004, p = 0.15 in adjusted analyses).

Conclusions

Our findings offer potential gestational-age-specific mechanisms linking maternal depressive symptoms during pregnancy via placental biology. Future studies will test whether these also link with adverse offspring outcomes.

Keywords

Depressionglucocorticoid receptorsmineralocorticoid receptorsplacentapregnancy
Type
Original Articles
Information
Psychological Medicine , Volume 45 , Issue 10 , July 2015 , pp. 2023 - 2030
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bonnin, A, Goeden, N, Chen, K, Wilson, ML, King, J, Shih, JC, Blakely, RD, Deneri, ES, Levitt, P (2011). A transient placental source of serotonin for the fetal forebrain. Nature 472, 347–350.CrossRefGoogle ScholarPubMed
Conradt, E, Lester, BM, Appleton, AA, Armstrong, DA, Marsit, CJ (2013). The roles of DNA methylation of NR3C1 and 11β-HSD2 and exposure to maternal mood disorder in utero on newborn behaviour. Epigenetics 8, 1321–1329.CrossRefGoogle Scholar
Cottrell, EC, Seckl, JR (2009). Prenatal stress, glucocorticoids and the programming of adult disease. Frontiers in Behavioural Neuroscience 3, 19.CrossRefGoogle ScholarPubMed
Devlin, AM, Brain, U, Austin, J, Oberlander, TF (2010). Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth. PLoS ONE 5, e12201.CrossRefGoogle ScholarPubMed
Edwards, CRW, Benediktsson, R, Lindsay, R, Seckl, JR (1993). Dysfunction of the placental glucocorticoid barrier: a link between the foetal environment and adult hypertension? Lancet 341, 355–357.CrossRefGoogle Scholar
Field, T (2011). Prenatal depression effects on early development: a review. Infant Behaviour and Development 34, 1–14.Google Scholar
Field, T, Diego, M, Dieter, J, Hernandez-Reif, M (2006). Prenatal depression effects on the fetus and the newborn: a review. Infant Behaviour and Development 29, 445–455.Google Scholar
Field, T, Diego, MA, Hernandez-Reif, M, Figueiredo, B, Ascencio, A, Schanberg, S, Kuhn, C (2008). Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. Depression and Anxiety 25, E1.CrossRefGoogle ScholarPubMed
Gotlib, IH, Joorman, J, Minor, KL, Hallmayer, J (2008). HPA axis reactivity: a mechanism underlying the associations among serotonin TLPR stress, and depression. Biological Psychiatry 63, 847–851.Google Scholar
Hogg, K, Price, EM, Hanna, CW, Robinson, WP (2012). Prenatal and perinatal environmental influences on the human fetal and placental epigenome. Clinical Pharmacology and Therapeutics 92, 716–726.Google Scholar
Hompes, T, Izzi, B, Gellens, E, Morreels, M, Fieuws, S, Pexsters, A, Schops, G, Dom, M, Van Bree, R, Freson, K, Verhaeghe, J, Spitz, B, Demyttenaere, K, Glover, V, Van den Bergh, B, Allegaert, K, Claes, S (2013). Investigating the influence of maternal cortisol and emotional state during pregnancy on the DNA methylation status of the glucocorticoid receptor gene (NR3C1) promoter region in cord blood. Journal of Psychiatric Research 47, 880–891.CrossRefGoogle ScholarPubMed
Murphy, VE, Smith, R, Giles, WB, Clifton, VL (2006). Endocrine regulation of human fetal growth: the role of the mother, placenta and fetus. Endocrine Reviews 27, 141–169.CrossRefGoogle ScholarPubMed
Nast, I, Bolten, M, Meinlschmidt, G, Hellhammer, DH (2013). How to measure prenatal stress? A systematic review of psychometric instruments to assess psychosocial stress during pregnancy. Paediatric and Perinatal Epidemiology 27, 313–322.Google Scholar
Novakovic, B, Saffery, R (2012). The ever growing complexity of placental epigenetics – role in adverse pregnancy outcomes and fetal programming. Placenta 33, 959–970.CrossRefGoogle ScholarPubMed
Oberlander, TF (2012). Fetal serotonin signaling: setting pathways for early childhood development and behavior. Journal of Adolescent Health 52, S9–S16.Google Scholar
Oberlander, TF, Weinberg, J, Papsdorf, M, Grunau, R, Misri, S, Devlin, AM (2008). Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 3, 97–106.Google Scholar
O'Donnell, K, O'Connor, TG, Glover, V (2009). Prenatal stress and neurodevelopment of the child: focus on the HPA axis and role of the placenta. Developmental Neuroscience 31, 285–292.CrossRefGoogle ScholarPubMed
O'Donnell, KJ, Bugge Jensen, A, Freeman, L, Khalife, N, O'Connor, TG, Glover, V (2012). Maternal prenatal anxiety and downregulation of placental 11β-HSD2. Psychoneuroendocrinology 37, 818–826.Google Scholar
O'Keane, V, Lightman, S, Marsh, M, Pawlby, S, Papadopoulos, AS, Taylor, A, Moore, R, Patrick, K (2011). Increased pituitary–adrenal activation and shortened gestation in a sample of depressed pregnant women: a pilot study. Journal of Affective Disorders 130, 300–305.Google Scholar
Olivier, JD, Akerud, H, Kaihola, H, Pawluski, JL, Skalkidou, A, Högberg, U, Sundström-Poromaa, I (2013). The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring. Frontiers in Cellular Neuroscience 7, 73.CrossRefGoogle ScholarPubMed
Ponder, KL, Salisbury, A, McGonnigal, B, Laliberte, A, Lester, B, Padbury, JF (2011). Maternal depression and anxiety are associated with altered gene expression in the human placenta without modification by antidepressant use: implications for fetal programming. Developmental Psychobiology 53, 711–723.Google Scholar
Radloff, L (1977). The CES-D Scale: a self-report symptom scale to detect depression in a community sample. Applied Psychological Measurement 1, 385–401.Google Scholar
Räikkönen, K, O'Reilly, JR, Pesonen, A-K, Kajantie, E, Villa, P, Laivuori, H, Hämäläinen, E, Seckl, JR, Reynolds, RM (2014). Lower maternal socioeconomic status is associated with increased placental glucocorticoid regeneration and sensitivity. Clinical Endocrinology 81, 175–182.Google Scholar
Räikkönen, K, Pesonen, AK, Roseboom, TJ, Eriksson, JG (2012). Early determinants of mental health. Best Practice and Research Clinical Endocrinology and Metabolism 26, 599–611.Google Scholar
Ressler, KJ, Nemeroff, CB (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety 12, 2–19.Google Scholar
Reynolds, RM, Jacobsen, GH, Drake, AJ (2013). What is the evidence in humans that DNA methylation changes link events in utero and later life disease? Clinical Endocrinology 78, 814–822.CrossRefGoogle ScholarPubMed
Rich-Edwards, JW, Mohllajee, AP, Kleinman, K, Hacker, MR, Majzoub, J, Wright, RJ, Gillman, MW (2008). Elevated midpregnancy corticotropin-releasing hormone is associated with prenatal, but not postpartum, maternal depression. Journal of Clinical Endocrinology and Metabolism 93, 1946–1951.CrossRefGoogle Scholar
Velasquez, JC, Goeden, N, Bonnin, A (2013). Placental serotonin: implications for the developmental effects of SSRIs and maternal depression. Frontiers in Cellular Neuroscience 7, 47.CrossRefGoogle ScholarPubMed
Villa, P, Kajantie, E, Räikkönen, K, Pesonen, AK, Hämäläinen, E, Vainio, M, Taipale, P, Laivuori, H, The Predo Study Group (2013). Aspirin in the prevention of pre-eclampsia in high-risk women: a randomized placebo-controlled PREDO Trial. British Journal of Obstetrics and Gynaecology 120, 64–74.CrossRefGoogle ScholarPubMed
Wyrwoll, CS, Holmes, MC (2012). Prenatal excess glucocorticoid exposure and adult affective disorders: a role for serotonergic and catecholamine pathways. Neuroendocrinology 95, 47–55.Google Scholar
Yehuda, R, Engel, SM, Brand, SR, Seckl, J, Marcus, SM, Berkowitz, GS (2005). Transgenerational effects of posttraumatic stress disorder in babies of mothers exposed to the World Trade Center attacks during pregnancy. Journal of Clinical Endocrinology and Metabolism 90, 4115–4118.Google Scholar